AbbVie Q2 Earnings Beats Consensus Slightly; Guides FY21 EPS Below Consensus

AbbVie Inc reports Q2 adjusted EPS of $3.11, marginally beating the consensus of $3.09.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.